Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.70 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.70 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | FDPS | P14324 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | MMP8 | P22894 | 1/20 | 0.40 |
| ▸ | MMP14 | P50281 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL1498179 | 1.00 | CYP3A4 (0.70) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| Phosphoric Acid SCHEMBL28147853 | 0.98 | CYP3A4 (0.68) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| Ammonia Solution, Strong SCHEMBL28201142 | 0.98 | CYP3A4 (0.68) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL27678596 | 0.98 | CYP3A4 (0.72) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL116247 | 0.98 | CYP3A4 (0.72) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| Alcohol SCHEMBL27536648 | 0.96 | CYP3A4 (0.66) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| Hexane SCHEMBL5390558 | 0.96 | CYP3A4 (0.66) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL3959360 | 0.96 | CYP3A4 (0.70) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL672901 | 0.96 | CYP3A4 (0.70) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL1396929 | 0.96 | CYP3A4 (0.70) | CYP3A4L3MBTL1TSHRTDP1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7312251-B2 | Synthesis of stable solutions of rare earth tris (organophosphate) in hydrocarbon solvents | RHODIA RARE EARTHS, INC. (US) | 2007-12-25 | — | — | US | disclosed |
| US-20040192950-A1 | Synthesis of stable solutions of rare earth tris (organophosphate) in hydrocarbon solvents | YUNLU KENAN (US) | 2004-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040192950-A1 | Synthesis of stable solutions of rare earth tris (organophosphate) in hydrocarbon solvents | PPIP5K2, TTPA, RTF1 | CYP3A4 2304/4885L3MBTL1 1675/4885TSHR 238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.